NCT05341492View on ClinicalTrials.gov

EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

May 1, 2030

Study Completion Date

May 1, 2035

Conditions
EGFR/ B7H3-positive Advanced Lung CancerEGFR/ B7H3-positive Advanced Triple-negative Breast Cancer
Interventions
BIOLOGICAL

EGFR/B7H3 CAR-T

2 × 10\^6/kg CAR-T cells,For subjects with body weight greater than 60 kg, the number of cells can only be calculated according to 60 kg of body weight.

Trial Locations (1)

Unknown

RECRUITING

Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
lead

Second Affiliated Hospital of Guangzhou Medical University

OTHER